- Home
- AKYA
as 12-20-2024 4:00pm EST
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 145.5M | IPO Year: | 2021 |
| Target Price: | $4.40 | AVG Volume (30 days): | 392.7K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.88 - $6.31 | Next Earning Date: | 11-14-2024 |
| Revenue: | $86,815,000 | Revenue Growth: | -4.98% |
| Revenue Growth (this year): | -13.48% | Revenue Growth (next year): | 11.76% |
Latest Akoya BioSciences Inc. News
AKYA Breaking Stock News: Dive into AKYA Ticker-Specific Updates for Smart Investing
MT Newswires
12 days ago
Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test
GlobeNewswire
12 days ago
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
GlobeNewswire
13 days ago
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
Simply Wall St.
a month ago
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook
Simply Wall St.
a month ago
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations
GuruFocus.com
a month ago
Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
Zacks
a month ago
Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates
Associated Press Finance
a month ago
Akoya: Q3 Earnings Snapshot
Compare AKYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AKYA Akoya BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.